Transcription of Reference ID: 3101735
{{id}} {{{paragraph}}}
Example: stock market
Reference ID: 3101735
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Docetaxel Injection safely and effectively. See full prescribing information for Docetaxel Injection. Docetaxel Injection, Solution for Intravenous Infusion Initial Approval: 1996 WARNING: TOXIC DEATHS, HEPATOTOXICITY, NEUTROPENIA, HYPERSENSITIVITY REACTIONS, and FLUID RETENTION See full prescribing information for complete boxed warning Treatment-related mortality increases with abnormal liver function, at higher doses, and in patients with NSCLC and prior platinum-based therapy receiving docetaxel at 100 mg/m2 ( ) Should not
FULL PRESCRIBING INFORMATION WARNING: TOXIC DEATHS, HEPATOTOXICITY, NEUTROPENIA, HYPERSENSITIVITY REACTIONS, and FLUID RETENTION The incidence of treatment-related mortality associated with docetaxel therapy is
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: